Product Information
PERAMPANEL 4 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $15.4239 per EA under NDC 00480706356. Its NADAC has been published 49 times since Sep 17, 2025.
FDA first approved this application on May 23, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480706356
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PERAMPANELApproval Type
Generic (ANDA)
FDA Application
ANDA209801FDA Approved
5/23/2025
TE Code
AB
On Market Since
5/29/2025
Pharmacological Classes
Price Statistics
The NADAC for PERAMPANEL 4 MG TABLET has been published 49 times since Sep 17, 2025, and over the history we have for it it has declined 50.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.4239 per EA |
|---|---|
| All-time high | $31.9257 (Feb 11, 2026) |
| All-time low | $15.4239 (Aug 19, 2026) |
| 52-week high | $31.9257 |
| 52-week low | $15.4239 |
| Median price | $29.8429 |
| Average price | $25.6230 |
| Largest weekly change | -19.8% (Apr 22, 2026) |
| Weeks tracked | 49 |
| Tracking since | Sep 17, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PERAMPANEL 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PERAMPANEL 4 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $15.4239 per EA (NDC 00480706356), effective Aug 19, 2026.
How has the price of PERAMPANEL 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for PERAMPANEL 4 MG TABLET has declined 50.7%. It has been tracked across 49 weekly CMS publications since Sep 17, 2025.
What are the highest and lowest recorded NADAC prices for PERAMPANEL 4 MG TABLET?
Since Sep 17, 2025, the NADAC for PERAMPANEL 4 MG TABLET has ranged from a low of $15.4239 (Aug 19, 2026) to a high of $31.9257 (Feb 11, 2026), with a median of $29.8429 per EA.
Are there cheaper alternatives to PERAMPANEL 4 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PERAMPANEL 4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PERAMPANEL 4 MG TABLET?
PERAMPANEL 4 MG TABLET (NDC 00480706356) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.